18 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
52
Small molecule inhibitors targeting activator protein 1 (AP-1).

University of Texas Medical Branch
4
Chemical constituents of Plectranthus amboinicus and the synthetic analogs possessing anti-inflammatory activity.

National Defense Medical Center, Taiwan
3
Quassinoid inhibition of AP-1 function does not correlate with cytotoxicity or protein synthesis inhibition.

National Cancer Institute-Frederick
118
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.

University of Oxford
2
Grassypeptolides F and G, cyanobacterial peptides from Lyngbya majuscula.

National Cancer Institute-Frederick
2
Nothospondin, a new AP-1 inhibitory quassinoid from the Cameroonian plant Nothospondias staudtii.

Nci-Frederick
77
Design, synthesis, and structure-activity relationship studies of thiophene-3-carboxamide derivatives as dual inhibitors of the c-Jun N-terminal kinase.

Sanford-Burnham Medical Research Institute
31
Synthesis and SAR of novel quinazolines as potent and brain-penetrant c-jun N-terminal kinase (JNK) inhibitors.

The Scripps Research Institute
7
Synthesis and evaluation of quinazolinone derivatives as inhibitors of NF-kappaB, AP-1 mediated transcription and eIF-4E mediated translational activation: inhibitors of multi-pathways involve in cancer.

B.V. Patel Pharmaceutical Education and Research Development Centre
1
Surveying polypeptide and protein domain conformation and association with FlAsH and ReAsH.

Yale University
1
Design, synthesis and evaluation of novel 2-thiophen-5-yl-3H-quinazolin-4-one analogues as inhibitors of transcription factors NF-kappaB and AP-1 mediated transcriptional activation: Their possible utilization as anti-inflammatory and anti-cancer agents.

B.V. Patel Pharmaceutical Education and Research Development Centre
4
Design, synthesis and characterization of novel 2-(2,4-disubstituted-thiazole-5-yl)-3-aryl-3H-quinazoline-4-one derivatives as inhibitors of NF-kappaB and AP-1 mediated transcription activation and as potential anti-inflammatory agents.

B.V. Patel Pharmaceutical Education and Research Development Centre
10
Structure-activity studies of phenanthroindolizidine alkaloids as potential antitumor agents.

Yale University
25
Synthesis and SAR of aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors.

Ucb Pharma
13
Hemodynamic effects of potent and selective JNK inhibitors in anesthetized rats: implication for targeting protein kinases in metabolic diseases.

Abbott Laboratories
24
Inhibitors of NF-kappaB and AP-1 gene expression: SAR studies on the pyrimidine portion of 2-chloro-4-trifluoromethylpyrimidine-5-[N-(3', 5'-bis(trifluoromethyl)phenyl)carboxamide].

Signal Pharmaceuticals
1
Melonoside B and Melonosins A and B, Lipids Containing Multifunctionalized ω-Hydroxy Fatty Acid Amides from the Far Eastern Marine Sponge Melonanchora kobjakovae.

Far Eastern Branch of The Russian Academy of Sciences
2
Characterization of a novel bivalent morphinan possessing kappa agonist and micro agonist/antagonist properties.

University of Rochester